Pricing Log in Create free account

Rallybio Corporation (RLYB) vs Tiziana Life Sciences Ltd (TLSA)

Rallybio Corporation and Tiziana Life Sciences Ltd are both Biotechnology companies. Rallybio Corporation and Tiziana Life Sciences Ltd are of similar size ($85.6M and $81.9M). Tiziana Life Sciences Ltd has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 3.3×. Across the 10 metrics below, Rallybio Corporation leads on 8 and Tiziana Life Sciences Ltd on 2.

Valuation

Metric RLYB TLSA Biotechnology median
P/E 3.35 n/m 10.26
P/S 104.84 — 9.18
P/B 0.97 n/m 2.05
Price to free cash flow 2.91 n/m 24.81
EV/EBITDA 0.03 0.04 0.65
EV/Sales (0.86) n/m 8.98
Earnings yield 29.87% (84.48%) (34.89%)
Free cash flow yield 34.41% 0.00% (24.52%)

Profitability

Metric RLYB TLSA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 34.52% 0.00% (50.12%)
Return on assets 32.85% 0.00% (45.60%)
Return on invested capital (944.36%) 0.00% 0.00%

Growth

Metric RLYB TLSA Biotechnology median
Revenue growth (TTM) 1.18% — 6.26%
EPS growth (last fiscal year) 85.06% (45.45%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RLYB TLSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 28.87 0.76 4.89
Net debt to EBITDA 1.63 0.19 1.01

Dividend

Metric RLYB TLSA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric RLYB TLSA Biotechnology median
Market cap 85.61m 81.86m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack